Ranbaxy gets US nod for Amoxicillin
Pharma major Ranbaxy Laboratories Ltd has received the green signal from the US regulatory authority to market its new dosage form of Amoxicillin, which is used to target bacterial infections in
Pharma major Ranbaxy Laboratories Ltd has received the green signal from the US regulatory authority to market its new dosage form of Amoxicillin, which is used to target bacterial infections in